Navigation Links
PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
Date:7/24/2012

BOSTON, July 24, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of  the PAREXEL BioPharm Unit -- a dedicated unit within PAREXEL focused solely on the unique needs of small and mid-sized biopharmaceutical companies to help them achieve their development goals.Recent data indicates[1] that small and mid-sized companies are the engine of the biopharmaceutical industry, with 81 percent of ongoing development programs originating from sponsors outside of the top 25 biopharmaceutical companies.  The PAREXEL BioPharm Unit seeks to support this critical pipeline by providing the precise expertise, global infrastructure, operational excellence and turn-key technologies needed to help small biopharmaceutical companies advance their drugs through the development cycle. Through vast experience and deep understanding of the needs of small and emerging biopharmaceutical companies, PAREXEL designed this new delivery model to provide a high level of attention and service. The goal is to provide a tailored solution that results in accelerated development timelines, reduced cost and a high level of quality.

"Small and mid-sized biopharmaceutical companies are truly the genesis of innovation and have been an important part of PAREXEL's client base for more than 30 years," said Ubavka DeNoble, Vice President of BioPharm Services. "The creation of the PAREXEL BioPharm Unit is especially important for small pharma and biotech sponsors that have needs that are meaningfully different from large pharma sponsors. The breadth and depth of our expertise gives us the ability to create customized solutions that are designed to meet the particular needs of each client -- whether the company is a small research venture, a growing mi
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
2. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
3. PAREXEL International To Present At NASDAQ OMX Investor Conference
4. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
5. PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening
6. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
9. Sanofi US Launches Collaborate Activate Innovation Challenge
10. Berg Pharma launches clinical trial on BPM 31543 for prevention of chemotherapy-induced alopecia (CIA)
11. Ellman International Launches Multi-stage Growth Plan With Acquisition Of Sandstone Medical Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , Oct. 17, 2014   InnFocus, Inc ., reported ... the United States for up to 3 years ... Summit in Chicago . The ... of the annual meeting of the American Academy of ... treated approximately 150 glaucoma patients in 6 countries by early ...
(Date:10/17/2014)... , Oct. 17, 2014  China Biologic Products, ... a leading fully integrated plasma-based biopharmaceutical company in ... the Company has received approval from the China ... manufacturing of human prothrombin complex concentrate ("PCC") at ... Taibang,s new coagulation factor production facility for Good ...
(Date:10/17/2014)... , Oct. 17, 2014   DaVita ... ), one of the nation,s largest and most ... DaVita University Academy – the company,s award-winning, leadership ... Nearly 2,000 DaVita teammates from around the globe ... DaVita University Academy is a two-day one-of-a-kind ...
Breaking Medicine Technology:InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3
... May 10, 2011 Cardica, Inc. (Nasdaq: CRDC ... and nine months ended March 31, 2011. Cardica,s management will ... to discuss the financial results and provide an update on ... diligently to bring our first anticipated commercial microcutter device, the ...
... 10, 2011 Cobalis Corp. (CLSC.PK) announced today they ... Allergy Defense Formula , on major national cable and ... featuring leading US allergist Dr. Paul H. Ratner, MD, ... allergies, giving seasonal and year-round sufferers the first truly ...
Cached Medicine Technology:Cardica Announces Fiscal 2011 Third Quarter Financial Results 2Cardica Announces Fiscal 2011 Third Quarter Financial Results 3Cardica Announces Fiscal 2011 Third Quarter Financial Results 4Cardica Announces Fiscal 2011 Third Quarter Financial Results 5Cardica Announces Fiscal 2011 Third Quarter Financial Results 6Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 2Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 3
(Date:10/20/2014)... 2014 hc1.com today announced the ... solution that enables healthcare organizations of all sizes ... customer relationship management (“CRM”) solution. , Designed from ... of the healthcare industry, the hc1 Healthcare Relationship ... patients by combining healthcare CRM, HIPAA-compliant collaboration, and ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Principle ... years, takes pride in manufacturing top-of-the-line absorbent products. ... image of its most popular brand, Tranquility® Premium Protection ... created a new website, gave its packaging a new ... bring the brand message to the public. , The ...
(Date:10/20/2014)... Succeed is proud to announce that they ranked ... the Every Body Walk! campaign by Kaiser Permanente. ... encourages workers to be more active outside of the workplace. ... at the end of September, was a friendly competition between ... Participating companies gave their staff pedometers and each day, ...
(Date:10/20/2014)... 2014 Unveiled at the Sept. 18 board ... conservatively estimates member hospital ROI on membership dues at 12.5. ... Center provides $12.50 in value to member hospitals. The calculation ... Member Dues)/Member Dues. , “This is the first time ... we think the methodology is really sound,” said Bill ...
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
Breaking Medicine News(10 mins):Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... Sam Smith as the new Chief Executive Officer of the international ... the International Board of Directors on Tuesday. , ... ... the unanimous confirmation of Sam Smith as the new Chief Executive ...
... Healthcare IT provider grows its operations in the Middle East , ... Systems Corporation (NYSE: PER ) ( www.perotsystems.com ) today ... to manage the pilot deployment of VistA - an open source ... a clinic in the capital, Amman. , ...
... EMPHYSEMA AT RISK FOR OSTEOPOROSIS , New research shows ... includes emphysema and chronic bronchitis, may also be at ... scans and pulmonary function tests on 65 male patients ... compare vertebral bone density with percentage of low attenuation ...
... D. England, MD, Professor and Chairman of Neurology at ... is the principal investigator of two studies recommending ... nerve disorder that to this time had few evidence-based ... two separate papers in the December 3, 2008 online ...
... The American Society of Hematology (ASH) will host its ... Marriott on Thursday, December 4, 2008, beginning at 8:00 ... hematology, the biological sciences, and medical research, is held ... year, students will have the opportunity to explore research ...
... N.J., Dec. 3 MedQuist Inc. (Nasdaq: MEDQ ... world, is pleased to announce the positive resolution of several ... Resolution of the DOJ Investigation , ... an administrative HIPAA subpoena for documents from the United States ...
Cached Medicine News:Health News:New CEO Takes Helm at Mercy Ships 2Health News:New CEO Takes Helm at Mercy Ships 3Health News:Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan 2Health News:Perot Systems Awarded Contract to Implement Health Information System in Kingdom of Jordan 3Health News:Journal CHEST: December highlighted studies 2Health News:LSUHSC's England leads development of new testing guidelines for common nerve disorder 2Health News:ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6
... oximeters available, Datex-Ohmeda s TuffSat is the ... transport, and EMS. TuffSat comes fully loaded ... index measurement) a quick, easy-to-use clinical ... perfusion at the sensor site. Now you ...
... A tool for Clinical Professionals and Researchers., ... an easy and efficient way to collect data ... minutes to days at selectable time intervals. With ... straight from the monitor via an interface cable ...
... care challenge., ,The S/5 Critical Care Monitor ... solution for the varying needs of critical care. ... of parameter module options, display and mounting options, ... optimize the bedside set-up to help meet your ...
... modular, easy to use., ,The S/5 ... small-footprint monitor ideally suited for medium care ... modules and Datex-Ohmeda supplies and accessories., ... the same user interface and features as ...
Medicine Products: